{
    "title": "Drug firm Concordia overcharged Britain's health service with 6,000 pct price rise",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-5103421/Drug-firm-Concordia-overcharged-Britains-health-service-6-000-pct-price-rise.html",
    "date": "2017-11-21",
    "keywords": [
        "concordia",
        "competition",
        "drug",
        "health",
        "cma",
        "law",
        "uk",
        "company",
        "service",
        "position",
        "price",
        "percent",
        "nhs",
        "medicine",
        "london",
        "countrys",
        "authority",
        "year",
        "decade",
        "pack",
        "executive",
        "andrea",
        "coscelli",
        "overcharge",
        "taxpayer",
        "market",
        "dominance",
        "supply",
        "regulator",
        "worldwide",
        "group",
        "turnover",
        "pfizer",
        "flynn",
        "antiepilepsy",
        "treatment",
        "phenytoin",
        "sodium",
        "number",
        "total",
        "paroxetine",
        "appeal",
        "hypothyroidism",
        "condition",
        "deficiency",
        "hormone",
        "equity",
        "part",
        "fact",
        "pricing",
        "liothyronine",
        "department",
        "period",
        "time",
        "investment",
        "availability",
        "healthcare",
        "agency",
        "investigation",
        "july",
        "evidence",
        "paul",
        "sandle",
        "editing",
        "louise"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}